Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Findley, H. W.
Right arrow Articles by Zhou, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Findley, H. W.
Right arrow Articles by Zhou, M.
Related Collections
Right arrow Neoplasia
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Expression and regulation of Bcl-2, Bcl-xl, and Bax correlate with p53 status and sensitivity to apoptosis in childhood acute lymphoblastic leukemia

HW Findley, L Gu, AM Yeager and M Zhou

Division of Pediatric Hematology/Oncology/Bone Marrow Transplantation, Emory University School of Medicine, Atlanta, GA 30322, USA.

Bcl-2 and its homologue, Bcl-x1, encode membrane-associated proteins that protect neoplastic cells from DNA damage-induced apoptosis, whereas Bax is a Bcl-2 antagonist that promotes cell death. In the present study, we examined the expression and regulation of these genes at both the mRNA and protein level in 22 pediatric acute lymphoblastic leukemia (ALL) cell lines, as well as their sensitivity to apoptosis after exposure to ionizing radiation (IR). Eleven of 22 lines expressed wild-type (wt) p53, 4 expressed mutant p53, and 7 did not express p53 (p53-null). Nine of 22 (41%) lines expressed Bcl-2; of these, 8 were wt- p53+ and 1 expressed mutant p53. Bcl-2 was not expressed in any p53- null lines. In contrast, all 22 lines were positive for Bcl-x1 and Bax, although expression level varied. Treatment with IR (10 Gy) induced both downregulation of Bcl-2 and upregulation of Bax at 2 to 5 hours post-IR in 5 of 8 (63%) wt-p53+ lines, leading to apoptosis. Conversely, lines that failed to both downregulate Bcl-2 and upregulate Bax after IR were resistant to apoptosis. Although levels of Bcl-x1 expression varied among the 22 lines, high levels of Bcl-x1 were observed in 5 of 7 (71%) p53- lines. There were no obvious changes in the expression of Bcl-x1 in these lines after IR. However, among the p53-null lines, resistance to IR was observed only in those expressing high levels of Bcl-x1. These results suggest that expression of Bcl-2 but not Bcl-x1 is p53-dependent and that IR-induced downregulation of Bcl-2 and upregulation of Bax occur in most wt-p53+ lines and are associated with radiosensitivity. Furthermore, high-level expression of Bcl-x1 occurs predominantly in p53-null lines and is associated with resistance to IR-induced apoptosis in these lines, indicating differential expression and regulation of Bcl-2 and Bcl-x1 in pediatric ALL.

Volume 89, Issue 8, pp. 2986-2993, 04/15/1997
Copyright © 1997 by The American Society of Hematology


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Molecular Cancer TherapeuticsHome page
Y. Xu, F. Fang, D. K. St. Clair, S. Josson, P. Sompol, I. Spasojevic, and W. H. St. Clair
Suppression of RelB-mediated manganese superoxide dismutase expression reveals a primary mechanism for radiosensitization effect of 1{alpha},25-dihydroxyvitamin D3 in prostate cancer cells
Mol. Cancer Ther., July 1, 2007; 6(7): 2048 - 2056.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Kubota, K. Kinoshita, K. Suetomi, A. Fujimori, and S. Takahashi
Mcl-1 Depletion in Apoptosis Elicited by Ionizing Radiation in Peritoneal Resident Macrophages of C3H Mice
J. Immunol., March 1, 2007; 178(5): 2923 - 2931.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
G Van de Putte, R Holm, A K Lie, M Baekelandt, and G B Kristensen
Markers of apoptosis in stage IB squamous cervical carcinoma
J. Clin. Pathol., June 1, 2005; 58(6): 590 - 594.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
T. Tonini, C. Gabellini, L. Bagella, G. D'Andrilli, V. Masciullo, G. Romano, G. Scambia, G. Zupi, and A. Giordano
pRb2/p130 Decreases Sensitivity to Apoptosis Induced by Camptothecin and Doxorubicin but not by Taxol
Clin. Cancer Res., December 1, 2004; 10(23): 8085 - 8093.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
F. H. Sarkar and Y. Li
Indole-3-Carbinol and Prostate Cancer
J. Nutr., December 1, 2004; 134(12): 3493S - 3498S.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. J. Waxman and P. S. Schwartz
Harnessing Apoptosis for Improved Anticancer Gene Therapy
Cancer Res., December 15, 2003; 63(24): 8563 - 8572.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Zhou, L. Gu, H. W. Findley, R. Jiang, and W. G. Woods
PTEN Reverses MDM2-mediated Chemotherapy Resistance by Interacting with p53 in Acute Lymphoblastic Leukemia Cells
Cancer Res., October 1, 2003; 63(19): 6357 - 6362.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y.-H. Wang, Z. Zhang, P. D. Burrows, H. Kubagawa, S. L. Bridges Jr, H. W. Findley, and M. D. Cooper
V(D)J recombinatorial repertoire diversification during intraclonal pro-B to B-cell differentiation
Blood, February 1, 2003; 101(3): 1030 - 1037.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. Zhou, L. Gu, F. Li, Y. Zhu, W. G. Woods, and H. W. Findley
DNA Damage Induces a Novel p53-Survivin Signaling Pathway Regulating Cell Cycle and Apoptosis in Acute Lymphoblastic Leukemia Cells
J. Pharmacol. Exp. Ther., October 1, 2002; 303(1): 124 - 131.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
F. H. Igney and P. H. Krammer
Immune escape of tumors: apoptosis resistance and tumor counterattack
J. Leukoc. Biol., June 1, 2002; 71(6): 907 - 920.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
X. M. Zhou, B. C. Y. Wong, X. M. Fan, H. B. Zhang, M. C. M. Lin, H. F. Kung, D. M. Fan, and S. K. Lam
Non-steroidal anti-inflammatory drugs induce apoptosis in gastric cancer cells through up-regulation of bax and bak
Carcinogenesis, September 1, 2001; 22(9): 1393 - 1397.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. Wieder, F. Essmann, A. Prokop, K. Schmelz, K. Schulze-Osthoff, R. Beyaert, B. Dorken, and P. T. Daniel
Activation of caspase-8 in drug-induced apoptosis of B-lymphoid cells is independent of CD95/Fas receptor-ligand interaction and occurs downstream of caspase-3
Blood, March 1, 2001; 97(5): 1378 - 1387.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
L. Karawajew, V. Ruppert, C. Wuchter, A. Kosser, M. Schrappe, B. Dorken, and W.-D. Ludwig
Inhibition of in vitro spontaneous apoptosis by IL-7 correlates with Bcl-2 up-regulation, cortical/mature immunophenotype, and better early cytoreduction of childhood T-cell acute lymphoblastic leukemia
Blood, July 1, 2000; 96(1): 297 - 306.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. Walczak, A. Bouchon, H. Stahl, and P. H. Krammer
Tumor Necrosis Factor-related Apoptosis-inducing Ligand Retains Its Apoptosis-inducing Capacity on Bcl-2- or Bcl-xL-overexpressing Chemotherapy-resistant Tumor Cells
Cancer Res., June 1, 2000; 60(11): 3051 - 3057.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. A. Katzenellenbogen, S. B. Baylin, and J. G. Herman
Hypermethylation of the DAP-Kinase CpG Island Is a Common Alteration in B-Cell Malignancies
Blood, June 15, 1999; 93(12): 4347 - 4353.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. M. Finucane, E. Bossy-Wetzel, N. J. Waterhouse, T. G. Cotter, and D. R. Green
Bax-induced Caspase Activation and Apoptosis via Cytochrome c Release from Mitochondria Is Inhibitable by Bcl-xL
J. Biol. Chem., January 22, 1999; 274(4): 2225 - 2233.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. Ohlsson, N. Kley, H. Werner, and D. LeRoith
p53 Regulates Insulin-Like Growth Factor-I (IGF-I) Receptor Expression and IGF-I-Induced Tyrosine Phosphorylation in an Osteosarcoma Cell Line: Interaction between p53 and Sp1
Endocrinology, March 1, 1998; 139(3): 1101 - 1107.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. H. Kaufmann, J. E. Karp, P. A. Svingen, S. Krajewski, P. J. Burke, S. D. Gore, and J. C. Reed
Elevated Expression of the Apoptotic Regulator Mcl-1 at the Time of Leukemic Relapse
Blood, February 1, 1998; 91(3): 991 - 1000.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
Sponsor: Genentech BioOncology and and Biogen Idec
Blood Online is supported in part by
Genentech BioOncology and Biogen Idec
  Copyright © 1997 by American Society of Hematology         Online ISSN: 1528-0020